September 2026
The global targeted DNA RNA sequencing market size is estimated to hit around USD 80.78 billion by 2035, increasing from USD 17.06 billion in 2026, with a CAGR of 18.92%.
September 2026
The U.S. targeted DNA RNA sequencing market size is accounted to hit around USD 27.72 billion by 2035 increasing from USD 5.73 billion in 2026, with a CAGR of 19.17%.
September 2026
The global DNA sequencing market size reached USD 16.89 billion in 2026 and is projected to reach around USD 57.39 billion by 2035 with a soild CAGR of 14.59%.
July 2025
The global DNA forensics market size was valued at USD 2.79 billion in 2024 and is projected to attain around USD 5.87 billion by 2034, with a CAGR of 7.18%.
September 2026
The submerged arc furnace market size stood at USD 3.08 billion in 2026, with major submerged arc furnace market companies including Hammers Industries Inc., YUEDA Stainless Steel Co., Ltd, DOSHI Technologies Pvt. Ltd., Tata Steel Processing & Distribution.
September 2026
The global recombinant DNA technology market size was valued at USD 973.64 billion in 2026 and is expected to hit around USD 1,719.89 billion by 2035, at a CAGR of 6.53%.
September 2026
The mRNA vaccines and therapeutics market size reached USD 130.20Â billion in 2026 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
September 2026
The global circRNA synthesis market size is accounted to hit around USD 909.12 million by 2035 increasing from USD 248.28 million in 2026, with a CAGR of 15.55%.
September 2026
The circulating tumor DNA (ctDNA) market size was USD 9.14 billion in 2026, with leading circulating tumor DNA (ctDNA) market players including Guardant Health, Roche Diagnostics, Illumina.
September 2026
The global biphasic external defibrillator market size was evaluated at USD 2.88 billion in 2026 and is predicted to hit around USD 5.48 billion by 2035, growing at a CAGR of 7.40%.
September 2026
The RNA interference drug delivery market was worth USD 139.58 billion in 2026, with key RNA interference drug delivery market players including Dicerna Pharmaceuticals (Acquired by Novo Nordisk), Silence Therapeutics, Ionis Pharmaceuticals.
September 2026
The global mRNA synthesis and manufacturing market size is estimated to hit around USD 5.64 billion by 2035 increasing from USD 3.38 billion in 2026, with a CAGR of 5.85%.
September 2026
The dairy alternatives market size was exhibited at USD 38.63 billion in 2026 and is predicted to hit around USD 102.74 billion by 2035 with a solid CAGR of 11.50%.
September 2026
The global alternative data market size is calculated at USD 21.61 billion in 2026 and is projected to hit around USD 854.34 billion by 2035 with a CAGR of 50.68%.
September 2026
The mRNA therapeutics market size was valued at USD 22.30 billion in 2026 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
September 2026
The global maternal mental health market size is calculated at USD 23.36 billion in 2026 and is projected to hit around USD 220.17 billion by 2035 with a CAGR of 28.38%.
September 2026
The global DNA diagnostics market size is accounted at USD 12.14 billion in 2026 and is projected to hit around USD 17.78 billion by 2035 with a CAGR of 4.32%.
September 2026
The internal neuromodulation devices market reached USD 15.67 billion in 2026, featuring leading internal neuromodulation devices market companies such as Medtronic plc, Abbott Laboratories, Boston Scientific Corporation.
September 2026
The global next-generation sequencing market is valued at USD 18.01 billion in 2026 and is expected to surpass around USD 66.95 billion by 2035 with a remarkable CAGR of 15.73% from 2026 to 2035.
September 2026
The alternative fuel and hybrid vehicle market size is projected to hit around USD 22,271.56 billion by 2035 from USD 1,309.23 billion in 2026 with a CAGR of 37.20%.
September 2026
The global small interfering RNA (siRNA) therapeutics market size is estimated to hit around USD 528.78 billion by 2035 increasing from USD 214.41 billion in 2026, with a CAGR of 10.55%.
September 2026
The global targeted therapeutics market size was estimated at USD 91.76 billion in 2026 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
September 2026
The global alternative fuel vehicle market is projected to hit around USD 1,314.44 billion by 2035 from USD 505.03 billion in 2026 with a CAGR of 11.59%
September 2026
The global complementary and alternative medicine market size is valued at USD 241.70 billion in 2026 and is expected to hit around USD 1,412.89 billion by 2035 with a CAGR of 22.00%.
September 2026
The global single cell sequencing market size is estimated to hit around USD 11.09 billion by 2035, increasing from USD 3.24 billion in 2026, with a CAGR of 14.67%.
September 2026
The internal combustion engine market demand is expected to surge around 5,58,977.43 thousand units by 2035 from 2,37,045.81 thousand units in 2025 with a CAGR of 8.96%.
September 2026
The global alternative protein market size was surpassed at USD 19.50 billion in 2026 and is predicted to attain around USD 38.91 billion by 2035 with a CAGR of 8%.
September 2026
The RNA editing therapies market expands with clinical progress in precision therapeutics, rare disease solutions, and gene-based medicine.
September 2026
The global targeted protein degradation analysis market size was evaluated at USD 6.74 billion in 2026 and is predicted to hit around USD 15.83 billion by 2035, growing at a CAGR of 9.95%.
September 2026
The global next-generation sequencing technologies market size is estimated to hit around USD 48.76 billion by 2035 increasing from USD 13.81 billion in 2026, with a CAGR of 15.05%.